Patient Zero is a modern hybrid cannabis strain derived from Pakistan Indica lineage. Developed for versatility within the cultivation environment, this strain requires a moderate level of expertise to manage throughout its 63-day flowering period. Growers can typically expect high yields from this cultivar, which is well-suited for both indoor and outdoor production settings.

The chemical profile of Patient Zero is defined by a complex array of twelve distinct terpenes, led by a dominant note of caryophyllene followed by myrcene, pinene, and limonene. The sensory experience is further nuanced by the presence of humulene, ocimene, and nerolidol, while traces of linalool, bisabolol, beta-pinene, guaiol, and p-cymene round out the aromatic profile. This layered terpene structure contributes to a specific olfactory and gustatory identity that reflects its Pakistan Indica ancestry.

As a THC-dominant variety, Patient Zero produces effects characterized by a sense of relaxation, happiness, and an uplifted mood. These therapeutic qualities make the strain a frequent choice for users addressing concerns related to stress, pain, and sleep. Beyond its immediate effects on the consumer, the strain has established a notable genetic legacy through its documented offspring, Urkle Bx1.